OmniAb (OABI) Other Working Capital Changes (2021 - 2026)
OmniAb (OABI) reported Other Working Capital Changes of -$512000.0 for Q1 2026, down 801.37% year-over-year from $73000.0 in Q1 2025, and up 13.07% on a QoQ basis from -$589000.0 in Q4 2025.
OmniAb (OABI) has 6 years of Other Working Capital Changes data on file, last reported at -$512000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 801.37% year-over-year to -$512000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 million (down 25.86% YoY) and the FY2025 annual result came in at -$1.6 million, up 34.32% from the prior year.
- Other Working Capital Changes grew to -$512000.0 in Q1 2026 per OABI's latest filing, from -$589000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.6 million in Q3 2023 and bottomed at -$3.0 million in Q1 2023.
- The 5-year median for Other Working Capital Changes is -$208000.0 (2025), against an average of -$297588.2.
- Peak annual rise in Other Working Capital Changes reached 1576.92% in 2023, while the deepest fall reached 4256.45% in 2023.
- Tracing OABI's Other Working Capital Changes over 5 years: stood at -$62000.0 in 2022, then sank by 4256.45% to -$2.7 million in 2023, then increased by 22.44% to -$2.1 million in 2024, then jumped by 71.89% to -$589000.0 in 2025, then rose by 13.07% to -$512000.0 in 2026.
- Per Business Quant, the three latest OABI Other Working Capital Changes figures stand at -$512000.0 (Q1 2026), -$589000.0 (Q4 2025), and -$876000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -512,000.00 |
| Mar 31, 2026 | -512,000.00 |
| Dec 31, 2025 | -589,000.00 |
| Dec 31, 2025 | -589,000.00 |
| Sep 30, 2025 | -876,000.00 |
| Sep 30, 2025 | -876,000.00 |
| Jun 30, 2025 | -208,000.00 |
| Jun 30, 2025 | -208,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | -2.10 Mn |
| Dec 31, 2024 | -2.10 Mn |
| Sep 30, 2024 | 888,000.00 |
| Sep 30, 2024 | 888,000.00 |
| Jun 30, 2024 | -602,000.00 |
| Jun 30, 2024 | -602,000.00 |
| Mar 31, 2024 | -627,000.00 |
| Mar 31, 2024 | -627,000.00 |
| Dec 31, 2023 | -2.70 Mn |
| Dec 31, 2023 | -2.70 Mn |
| Sep 30, 2023 | 2.60 Mn |
| Sep 30, 2023 | 2.60 Mn |
| Jun 30, 2023 | 768,000.00 |
| Jun 30, 2023 | 768,000.00 |
| Mar 31, 2023 | -2.99 Mn |
| Mar 31, 2023 | -2.99 Mn |
| Dec 31, 2022 | -62,000.00 |
| Dec 31, 2022 | -62,000.00 |
| Sep 30, 2022 | 1.51 Mn |
| Sep 30, 2022 | 1.51 Mn |
| Jun 30, 2022 | -52,000.00 |
| Jun 30, 2022 | -52,000.00 |
| Mar 31, 2022 | 417,000.00 |
| Mar 31, 2022 | 417,000.00 |
| Dec 31, 2021 | -248,112.00 |
| Dec 31, 2021 | -248,112.00 |